Page 19 - 202010
P. 19
5.6 科学设定补偿标准 frequently asked questions[EB/OL].[2019-01-19].https://
我国预防接种异常反应补偿标准各省间差异大、补 www.hrsa.gov/vaccine-compensation/FAQ/index.html.
偿水平低、补偿不充分的问题由来已久,由此产生的矛 [ 8 ] Federal Register. National Vaccine Injury Compensa-
盾和纠纷也从未停止。为此,《疫苗管理法》第五十六条 tion Program:revisions to the vaccine injury table[EB/
第三款规定:“预防接种异常反应补偿范围、标准、程序 OL].[2019-09-03]. http://www.gpo.gov/fdsys/pkg/FR-2015-
07-29/pdf/2015-17503.pdf.
由国务院规定,省、自治区、直辖市制定具体实施办
[ 9 ] HRSA. The National Vaccine Injury Compensation Pro-
法”。该条款为我国建立全国统一的补偿体系奠定了基
gram(VICP)Division of Injury Compensation Programs
础,各省补偿标准不统一的问题有望得到缓解。但考虑
Update(DICP)Advisory Commission on Childhood Vac-
到我国还是发展中国家,经济发展地区不平衡现象依然
cines (ACCV) [EB/OL]. (2019-06-06) [2019-09-03].
十分明显,因此不可能照搬美国的补偿标准并实行全国 https://www.hrsa.gov/sites/default/files/hrsa/advisory-co-
统一。所谓的补偿标准统一应是指补偿金计算公式或 mmittees/vaccines/meetings/2019/06062019-dicp-update.
方法一致,公式中的变量(如城镇居民人均可支配收入、 pdf.
职工平均工资等)还应参照各省经济发展水平而定,变 [10] USCFC. Guidelines for practice under the National Vac-
量的选择将直接决定申请人最终可获得补偿金额的多 cine Injury Compensation Program of the office of special
少。建议参照我国最高人民法院《关于审理人身损害赔 masters[EB/OL].[2019-08-22]. http://www.uscfc.uscourts.
偿案件适用法律若干问题的解释》(法释〔2003〕20号)规 gov/sites/default/files/GUIDELINES%20FOR%20PRAC-
定的人身损害赔偿标准,科学设定补偿金计算参数和补 TICE%20%208.22.2019.pdf.
偿费用类型。在疫苗补偿基金运作良好的情况下,可考 [11] HRSA. National Vaccine Injury Compensation Program
data report[EB/OL].[2019-09-03]. https://www.hrsa.gov/
虑将精神损害也纳入补偿范围,进一步提高补偿水平。
vaccine-compensation/data/index.html.
综上所述,预防接种异常反应补偿制度是确保《疫
[12] DRAKE B,TIEMAN AM. National Childhood Vaccine
苗管理法》落地的基础制度,对疫苗行业的发展和社会
Injury Act of 1986:using tax revenues to assure vaccine
秩序的稳定起着举足轻重的作用,需要在后续实施过程
availability[J]. Public Budgeting Financ,1994,14(2):54-
中加以改进和完善。 64.
参考文献 [13] JOHNSON JMT. Use of expert testimony,specialized deci-
[ 1 ] 杜仪方.“恶魔抽签”的赔偿与补偿:日本预防接种损害中 sion makers,and management innovations in the National
的国家责任[J].法学家,2011,26(1):154-162、180. Vaccine Injury Compensation Program[EB/OL].(1998-01-
[ 2 ] LOOKER C,KELLY H. No-fault compensation following 01)[2019-07-25]. https://www.fjc.gov/sites/default/files/
adverse events attributed to vaccination:a review of inter- 2012/VacInjur.pdf.
national programmes[J]. Bull World Health Organ,2011, [14] RIDGWAY D. No-fault vaccine insurance:lessons from
89(5):371-378. the National Vaccine Injury Compensation Program[J]. J
[ 3 ] 赖红梅.疫苗损害法律问题研究[M].北京:法律出版社, Health Polit Policy Law,1999,24(1):59-90.
2018:127. [15] ZHOU W,POOL V,ISKANDER JK,et al. Surveillance
[ 4 ] ABRAMSON BD. Vaccine,vaccination,and immunization for safety after immunization:vaccine adverse event re-
law[M]. Washington,D.C.:BNA Books,2018:94. porting system(VAERS):United States,1991-2001[J].
[ 5 ] DAVIS TH JR,BOWMAN CB. No-fault compensation for MMWR Surveill Summ,2003,52(1):1-24.
unavoidable injuries:evaluating the national childhood [16] GAO. Vaccine injury compensation:most claims took mul-
vaccine injury compensation program[J]. Univ Dayton tiple years and many were settled through negotia-
Law Rev,1991,16(2):277-312. tion [EB/OL].(2014-11-21)[2019-06-26]. https://www.
[ 6 ] FindLaw. Summary of current issues in the National Vac- gao.gov/products/GAO-15-142.
cine Injury Compensation Program[EB/OL].(2016-05- [17] MARINER WK. Legislative report:the National Vaccine
03)[2019-06-27]. https://corporate.findlaw.com/litigation- Injury Compensation Program[EB/OL].[2019-07-25].
disputes/summary-of-current-issues-in-the-national-vacc- https://www.healthaffairs.org/doi/10.1377/hlthaff.11.1.255.
ine-injury.html. (收稿日期:2019-11-15 修回日期:2020-04-04)
[ 7 ] HRSA. National Vaccine Injury Compensation Program, (编辑:段思怡)
中国药房 2020年第31卷第10期 China Pharmacy 2020 Vol. 31 No. 10 ·1165 ·